Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will present at the following investor conferences:
- Cowen and Company 33rd Annual Health Care Conference, Boston, March 4, 2013, at 4:50 p.m. ET
- Barclays Global Healthcare Conference, Miami, March 12, 2013, at 9:30 a.m. ET
- Bernstein Emerging Biotech Conference 2013, Snowbird, UT, March 12, 2013, at 4:00 p.m. MT (2:00 p.m. ET) (no webcast available)
The presentations at the Cowen and Company and Barclays conferences will be webcast. Live audio webcasts and replays of these presentations will be accessible on the “investors/media” section of the company's website, www.infi.com, and will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs focused on the inhibition of phosphoinositide-3-kinase and heat shock protein 90 are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at